| |
| |
|
| Insider
Information: |
Moorin Jay |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
11,855,674 |
|
|
Indirect Shares
|
4,615,873 |
|
|
| Direct
Value |
$5,545 |
|
|
|
Indirect Value
|
$4,421,039 |
|
|
| Total
Shares |
16,471,547 |
|
|
| Total
Value |
$4,426,584 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Welltek Incorporated |
WTKND |
Director |
|
0 |
2003-11-05 |
1,435,407 |
Premium* |
|
|
Cypress Bioscience Inc |
CYPB |
10% Owner |
2003-10-14 |
50,000 |
2004-01-27 |
940,372 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-15 |
0 |
2006-05-15 |
1,855,275 |
Premium* |
|
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
2007-09-11 |
2,922,169 |
2007-08-21 |
0 |
Premium* |
|
|
Pegasi Energy Resources |
PGSI |
Director |
2014-01-31 |
5,544,890 |
2014-01-31 |
303,168 |
Premium* |
|
|
Eagle Pharmaceuticals, Inc. |
EGRX |
Director, 10% Owner |
|
0 |
2014-02-18 |
81,651 |
Premium* |
|
|
Immune Design Corp. |
IMDZ |
10% Owner |
2014-07-29 |
2,695,757 |
2014-07-29 |
0 |
Premium* |
|
|
Arno therapeutics Inc |
ARNI |
Director |
2016-01-12 |
642,858 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
32 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2007-08-31 |
4 |
S |
$14.00 |
$287,321 |
D/D |
(20,200) |
2,940,769 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2007-08-31 |
4 |
S |
$14.36 |
$830,315 |
D/D |
(57,400) |
2,960,969 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • – |
2006-05-15 |
4 |
B |
$6.50 |
$2,499,998 |
I/I |
384,615 |
1,855,275 |
2.1 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2014-07-29 |
4 |
S |
$12.00 |
$2,500,008 |
D/D |
(208,334) |
2,304,626 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2014-07-29 |
4 |
B |
$12.00 |
$4,693,572 |
D/D |
391,131 |
2,695,757 |
2.45 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • • |
2014-02-18 |
4 |
B |
$15.00 |
$4,999,995 |
I/I |
333,333 |
4,770,828 |
2.25 |
- |
|
| CYPB |
Cypress Bioscience Inc |
10% Owner |
– – • |
2004-01-27 |
4 |
D |
$13.00 |
$17,066,218 |
I/I |
(1,312,786) |
940,372 |
|
- |
|
32 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
